Novartis (NVS) Confirms FDA Approval for Expanded Use of Zykadia®
Tweet Send to a Friend
Novartis (NYSE: NVS) today announced the US Food and Drug Administration (FDA) approved the expanded use of Zykadia® (ceritinib) to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE